Xbrane Biopharma AB (DE:7XB)
BERLIN:7XB
Germany Market

Xbrane Biopharma AB (7XB) Balance Sheet

1 Followers

Xbrane Biopharma AB Balance Sheet

Xbrane Biopharma AB's total assets for Q4 2022 were kr690.51M, an increase of 18.55% from the previous quarter. DE:7XB total liabilities were kr265.63M for the fiscal quarter, a 3.88% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Assets
kr 690.51Mkr 688.43Mkr 463.76Mkr 338.94Mkr 252.88M
Total Liabilities
kr 265.63Mkr 256.69Mkr 206.06Mkr 179.59Mkr 169.81M
Total Equity Gross Minority
kr 424.89Mkr 431.74Mkr 257.71Mkr 159.35Mkr 83.07M
Total Capitalization
kr 424.89Mkr 431.74Mkr 257.71Mkr 159.35Mkr 83.08M
Preferred Stock Equity
-----
Capital Lease Obligations
kr 38.22Mkr 44.38Mkr 6.26Mkr 9.43Mkr 451.00K
Currency in SEK

Xbrane Biopharma AB Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis